NCT05224635

Brief Summary

Evidence suggests that the rate of treatable vascular injury is increasing due to improved pre-hospital strategies. The increased rate of vascular trauma occurs in an era of increased sub-specialization, shifting training paradigms and the emergence of endovascular therapies. These factors, in combination with the baseline complexity of vascular trauma, make it particularly important that the management of this injury pattern be evidence-based. However, because all forms and distributions of vascular injury represent only 4% to 9% of trauma admissions, meaningful study of one injury pattern, patient population, therapeutic or surveillance strategy is difficult at a single institution. Further complicating such efforts is the fact that vascular trauma is managed by a wide range of surgical and now endovascular specialists, further fragmenting even a busy trauma institution's experience with vascular injury.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,718

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 30, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 3, 2022

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 4, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

March 27, 2024

Status Verified

March 1, 2024

Enrollment Period

3 years

First QC Date

February 3, 2022

Last Update Submit

March 26, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • establish an aggregate database

    establish an aggregate database of information of vascular trauma measured by Injury Severity Score (ISS): (range 0-75)

    the 1st of November 2021 through 1st of July 2024

Study Arms (1)

subjects presenting to the emergency room

Chart review will include subjects presenting to the emergency room from the 1st of November 2021 through 1st of July 2024.

Procedure: Vascular Injury

Interventions

The Society of Vascular Surgery has established a robust vascular disease registry but this organization's focus is on vascular disease and lacks capture of the data points necessary to discern trauma-specific outcomes. Recent military experience from the United States and United Kingdom, including the Balad Vascular Registry and the Global War on Terror (GWOT) Vascular Registry have provided a contemporary assessment of wartime vascular injury, but again these studies have been retrospective case series and registry reviews. Furthermore, applications of lessons learned in wartime vascular injury do not completely translate to management in trauma centers in the United States.

subjects presenting to the emergency room

Eligibility Criteria

Age16 Years+
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

• Adult trauma patients; defined by the American College of Surgeons as individuals age: ≥16 years

You may qualify if:

  • Adult trauma patients; defined by the American College of Surgeons as individuals age: ≥16 years
  • CT/CTA, duplex, angiographic or clinical/ operative diagnosis of vascular injury following trauma
  • Initial management at Methodist Dallas Medical Center

You may not qualify if:

  • Age: \< 16 years
  • No diagnosis of vascular injury
  • Prisoner
  • Subject transferred from another medical facility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Methodist Dallas Medical Center

Dallas, Texas, 75203, United States

Location

MeSH Terms

Conditions

Vascular System Injuries

Interventions

SPEG protein, human

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesWounds and Injuries

Study Officials

  • Jennifer Burris, M.D.

    Methodist Health System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 3, 2022

First Posted

February 4, 2022

Study Start

December 30, 2021

Primary Completion

December 30, 2024

Study Completion

December 30, 2024

Last Updated

March 27, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations